New predictive equations for spirometric reference values and comparison with Morris equation in a Korean population

Respirology

Volumn 13, Issue 3, 2008, Pages 365-371

  Lee, Chang Hoon ^a   Lee, Ju Young ^b   Jang, Eun Jung ^b   Park, Keun Yong ^b   Han, Hyun Woo ^b  

^a Seoul National University College of Medicine   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Airway; COPD; Morris equation; Obstructive airway disease; Reference value; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; REFERENCE VALUE; SOUTH KOREA; SPIROMETRY;

ADULT; AGED; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH SURVEYS; HUMANS; KOREA; LUNG DISEASES; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SPIROMETRY;

EID: 41849141574     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2008.01264.x     Document Type: Article

References (40)

1. American Thoracic Society. Standardization of spirometry, 1994 Update. Am. J. Respir. Crit. Care Med. 1995 152 : 1107 36.
2. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am. Rev. Respir. Dis. 1991 144 : 1202 18.
3. Crapo RO, Morris AH, Gardner RM. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 1981 123 : 659 64.
4. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Am. Rev. Respir. Dis. 1976 113 : 587 600.
5. Morris JF, Koski A, Johnson LC. Spirometric standards for healthy nonsmoking adults. Am. Rev. Respir. Dis. 1971 103 : 57 67.
6. Schoenberg JB, Beck GJ, Bouhuys A. Growth and decay of pulmonary function in healthy blacks and whites. Respir. Physiol. 1978 33 : 367 93.
7. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am. J. Respir. Crit. Care Med. 1999 159 : 179 87.
8. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. Suppl 1993 16 : 5 40.
9. Kaplan JB, Bennett T. Use of race and ethnicity in biomedical publication. JAMA 2003 289 : 2709 16.
10. Schwartz J, Katz SA, Fegley RW, Tockman MS. Sex and race differences in the development of lung function. Am. Rev. Respir. Dis 1988 138 : 1415 21.
11. Chehreh MN, Young RC Jr., Viaene H, Ross CW, Scott RB. Spirometric standards for healthy inner-city black children. Am. J. Dis. Child 1973 126 : 159 63.
12. Rode A, Shephard RJ. Pulmonary function of Canadian Eskimos. Scand. J. Respir. Dis. 1973 54 : 191 205.
13. Veale AJ, Peat JK, Salome CM, Woolcock AJ, Thompson JE. 'Normal' lung function in rural Australian aborigines. Aust. N. Z. J. Medical 1997 27 : 543 9.
14. Golshan M, Nematbakhsh M, Amra B, Crapo RO. Spirometric reference values in a large Middle Eastern population. Eur. Respir. J. 2003 22 : 529 34.
15. Fulambarker A, Copur AS, Javeri A, Jere S, Cohen ME. Reference values for pulmonary function in Asian Indians living in the United States. Chest 2004 126 : 1225 33.
16. Sharp DS, Enright PL, Chiu D, Burchfiel CM, Rodriguez BL et al. Reference values for pulmonary function tests of Japanese-American men aged 71-90 years. Am. J. Respir. Crit. Care Med. 1996 153 : 805 11.
17. Woo J, Pang J. Spirometry in healthy elderly Chinese. Thorax 1988 43 : 617 20.
18. Korotzer B, Ong S, Hansen JE. Ethnic differences in pulmonary function in healthy nonsmoking Asian-Americans and European-Americans. Am. J. Respir. Crit. Care Med. 2000 161 : 1101 8.
19. de Marco R, Zanolin ME, Accordini S, Signorelli D, Marinoni A et al. A new questionnaire for the repeat of the first stage of the European Community Respiratory Health Survey: a pilot study. Eur. Respir. J. 1999 14 : 1044 8.
20. Fletcher CMPR, Tinker C, Speizer F. Natural History Chronic Bronchitis Emphysema. Oxford : Oxford University Press, 1976 24 31, 78 85, 151.
21. Shin C, Lee S, Abbott RD, Kim JH, Lee SY et al. Relationships between respiratory symptoms and FEV1 in men and women with normal lung function: The Korean Health and Genome Study. Lung 2005 183 : 301 9.
22. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am. J. Respir. Crit. Care Med. 2001 163 : 1256 76.
23. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. Engl. J. Med. 2004 350 : 1005 12.
24. Choi JK, Paek DM, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc. Lung Dis. (Korean) 2005 58 : 230 42.
25. Lee JM, Kim EJ, Kang MJ, Son JW, Lee SJ et al. The influence of aging on pulmonary function tests in elderly Korean population. Tuberc. Lung Dis. (Korean) 2000 49 : 752 9.
26. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F et al. Interpretative strategies for lung function tests. Eur. Respir. J. 2005 26 : 948 68.
27. Kim DS, Kim YS, Jung KS, Chang JH, Lim CM et al. Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey. Am. J. Respir. Crit. Care Med. 2005 172 : 842 7.
28. Korean Statistical Information Service. Causes of death in Korea (in Korean). [Accessed 20 March 2008.] Available from URL: http://www.kosis.kr
29. Sin DD, McAlister FA, Man SF, Anthonisen NR. Contemporary management of chronic obstructive pulmonary disease: scientific review. JAMA 2003 290 : 2301 12.
30. Ram FS, Sestini P. Regular inhaled short acting beta2 agonists for the management of stable chronic obstructive pulmonary disease: Cochrane systematic review and meta-analysis. Thorax 2003 58 : 580 4.
31. Sin DD, Wu L, Anderson JA, Anthonisen NR, Buist AS et al. Inhaled corticosteroids and mortality in chronic obstructive pulmonary disease. Thorax 2005 60 : 992 7.
32. Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 2003 58 : 937 41.
33. Barr RG, Bourbeau J, Camargo CA, Ram FS. Inhaled tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2005 2 : CD002876.
34. Glaab T, Banik N, Trautmann M, Hellmann A, Wencker M. Guideline-conformity of outpatient COPD management by pneumologists. Pneumologie 2006 60 : 395 400. (in German).
35. Incalzi RA, Corsonello A, Pedone C, Masotti G, Bellia V et al. From Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to current clinical practice: an overview of the pharmacological therapy of stable chronic obstructive pulmonary disorder. Drugs Aging 2006 23 : 411 20.
36. Decramer M, Bartsch P, Pauwels R., Yernault JC. Management of COPD according to guidelines. A national survey among Belgian physicians. Monaldi Arch. Chest Dis 2003 59 : 62 80.
37. World Health Organization: Regional Office for the Western Pacific. Smoking statistics [Accessed 20 March 2008.] Available from URL: http://www.wpro.who.int/media_centre/fact_sheets/fs_20020528.htm
38. Smith AA, Gaensler EA. Timing of forced expiratory volume in one second. Am. Rev. Respir. Dis. 1975 112 : 882 5.
39. ATS statement - Snowbird workshop on standardization of spirometry. Am. Rev. Respir. Dis. 1979 119 : 831 8.
40. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R et al. Standardisation of spirometry. Eur. Respir. J. 2005 26 : 319 38.